Greyson's Trilexon(R) System Receives Trademark Approval
Main Category: Cosmetic Medicine / Plastic SurgeryAlso Included In: Regulatory Affairs / Drug Approvals
Article Date: 23 Apr 2009 - 1:00 PDT
| Patient / Public: | ![]() |
1 (1 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
GREYSON INTERNATIONAL, INC. (GYSN.PK) has been awarded trademark approval for Trilexon®, a new delivery system which will improve the effectiveness of virtually every topical application in today's cosmetic market and every over-the-counter topical drug application.
The first products featuring the Trilexon® system are skin-care products that are currently in the preparation stage to be sold in the marketplace.
"We are pleased to announce that Trilexon® is now a registered trademark of Greyson International," said Greyson International President and CEO Harvey Tauman. "This is a very important step for us as we move forward from the developmental and research stage into the marketing and sales stage for Greyson's products and applications."
About Greyson International, Inc.
Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application in today's cosmetic market and every over-the-counter topical drug application. Trilexon® is a registered trademark of Greyson International. For more information, visit http://www.greysonproducts.com.
This release contains information about management's view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.
Source
Greyson International, Inc
Visit our cosmetic medicine / plastic surgery section for the latest news on this subject.
MLA
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/147111.php>
APA
http://www.medicalnewstoday.com/releases/147111.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





